Fig. 2From: Minorities with lupus nephritis and medications: a study of facilitators to medication decision-makingPrioritized facilitators to help patients make decisions about treatment choices in Caucasian patients in nominal groups 1 (a) and 2 (b). CA, Caucasian, SES socioeconomic status, UAB University of Alabama at BirminghamBack to article page